These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34309061)

  • 1. Diabetes distress and glycaemic control in young adults with type 1 diabetes: Associations by use of insulin pumps and continuous glucose monitors.
    Nagel KE; Dearth-Wesley T; Herman AN; Smith HG; Whitaker RC
    Diabet Med; 2021 Nov; 38(11):e14660. PubMed ID: 34309061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real time continuous glucose monitoring in high-risk people with insulin-requiring type 2 diabetes: A randomised controlled trial.
    Lever CS; Williman JA; Boucsein A; Watson A; Sampson RS; Sergel-Stringer OT; Keesing C; Chepulis L; Wheeler BJ; de Bock MI; Paul RG
    Diabet Med; 2024 Aug; 41(8):e15348. PubMed ID: 38758653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 Subjects.
    Walsh J; Roberts R; Weber D; Faber-Heinemann G; Heinemann L
    J Diabetes Sci Technol; 2015 Jun; 9(5):1103-10. PubMed ID: 26071425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
    Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
    Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
    Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
    Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets.
    Tanenbaum ML; Hanes SJ; Miller KM; Naranjo D; Bensen R; Hood KK
    Diabetes Care; 2017 Feb; 40(2):181-187. PubMed ID: 27899489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic control in transition-aged versus early adults with type 1 diabetes and the effect of a government-funded insulin pump programme.
    Mooney SP; Booth GL; Shulman R; Na Y; Weisman A; Shah BR; Perkins BA; Lipscombe L
    Diabet Med; 2021 Nov; 38(11):e14618. PubMed ID: 34076916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of insulin pump therapy on key parameters of diabetes management and diabetes related emotional distress in the first 12 months.
    Oldham V; Mumford B; Lee D; Jones J; Das G
    Diabetes Res Clin Pract; 2020 Aug; 166():108281. PubMed ID: 32628980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
    Foster NC; Beck RW; Miller KM; Clements MA; Rickels MR; DiMeglio LA; Maahs DM; Tamborlane WV; Bergenstal R; Smith E; Olson BA; Garg SK
    Diabetes Technol Ther; 2019 Feb; 21(2):66-72. PubMed ID: 30657336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. During an 18-month course of automated insulin delivery treatment, children aged 2 to 6 years achieve and maintain a higher time in tight range.
    Pulkkinen MA; Varimo TJ; Hakonen ET; Hero MT; Miettinen PJ; Tuomaala AK
    Diabetes Obes Metab; 2024 Jun; 26(6):2431-2438. PubMed ID: 38514384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of glycaemic outcome in the current practice of care for young people up to 21 years old with type 1 diabetes under real-life conditions.
    Kordonouri O; Lange K; Biester T; Datz N; Kapitzke K; von dem Berge T; Weiskorn J; Danne T
    Diabet Med; 2020 May; 37(5):797-804. PubMed ID: 31498923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring and Glycemic Control in Young Adults with Type 1 Diabetes: Benefit for Even the Simplest Insulin Administration Methods.
    Toschi E; Atakov-Castillo A; Clift A; Bennetti M; Gabbay RA
    Diabetes Technol Ther; 2021 Aug; 23(8):586-589. PubMed ID: 33729833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital.
    Courtney A; Smith D; Forde H
    Ir J Med Sci; 2023 Dec; 192(6):2763-2768. PubMed ID: 36940009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between use of diabetes technology and diabetes distress: a Danish cross-sectional survey of adults with type 1 diabetes.
    Lorenzen JT; Madsen KP; Cleal B; Joensen LE; Nørgaard K; Pedersen-Bjergaard U; Schmidt S; Rytter K; Willaing I
    BMJ Open; 2024 Mar; 14(3):e080053. PubMed ID: 38531585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between dispositional mindfulness and glycemic control in type 1 diabetes during early adulthood: Differences by age and adverse childhood experiences.
    Nagel KE; Dearth-Wesley T; Herman AN; Smith HG; Gandica RG; Golden LH; Weil HFC; Whitaker RC
    Pediatr Diabetes; 2020 Jun; 21(4):681-691. PubMed ID: 32090426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrum.
    Holmes-Walker DJ; Abraham MB; Chee M; Jones TW;
    Intern Med J; 2023 Jan; 53(1):61-67. PubMed ID: 34142758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric estimated average glucose in children with Type 1 diabetes.
    O'Riordan SM; Danne T; Hanas R; Peters CJ; Hindmarsh P
    Diabet Med; 2014 Jan; 31(1):36-9. PubMed ID: 23869869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
    Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
    Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.